IMCR

Immunocore Holdings
IMCR

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$1.56B
EV
$1.16B
Shares Outstanding
50.28M
Beta
0.78

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$62.18
P/E 2025E
-
P/Revenue 2025E
4.13x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Immunocore Holdings plc

gainify
IMCR

Immunocore Holdings plc

IMCR

Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic...

Sector

Healthcare

Industry

Biotechnology

CEO

Jallal, Bahija

Employees

493

IPO Date

2021-02-05

Headquarters

92 Park Drive, Milton Park, Abingdon, Oxfordshire, OX14 4RY, United Kingdom

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.